Argos gets incentives for facility; Ceva invests $23M in sterile vet drug plant; India threatens researchers;

> Argos Therapeutics ($ARGS) will get $9.3 million in public support to help build a 100,000-square-foot facility in Raleigh, NC, to manufacture an oncology drug candidate. Release

> Ceva Animal Health ($CEVA) has invested about €18 million ($22.7 million) to expand injectable drug capacity at its plant in Libourne, France. Release

> DPx Holdings has renamed its DSM Fine Chemicals business unit as DPx Fine Chemicals. Release

> Capsugel has received the EXCiPACT certification for its sites in Bornem, Belgium, and Colmar, France, indicating it meets GMP standards and EU regulations for its empty, two-piece hard capsules. Release

And Finally... The Indian government is considering legal action against the American Enterprise Institute, Roger Bates and other authors of a report alleging that India has been selling subpar drugs to Africa. Story